Synthetic API and Its Role in the Expanding Active Pharmaceutical Ingredient Market The pharmaceutical industry is undergoing rapid transformation, driven by advances in manufacturing technologies, increasing global healthcare demand, and innovation in drug development. At the heart of this transformation lies the Synthetic Active Pharmaceutical Ingredient (API) segment, which plays a crucial...

According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...